SomaLogic (SLGC) Stock Forecast, Price Target & Predictions
SLGC Stock Forecast
SomaLogic stock forecast is as follows: an average price target of $12.00 (represents a 471.43% upside from SLGC’s last price of $2.10) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
SLGC Price Target
The average price target for SomaLogic (SLGC) is $12.00 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $15.00 to $9.00. This represents a potential 471.43% upside from SLGC's last price of $2.10.
SLGC Analyst Ratings
According to 4 Wall Street analysts, SomaLogic's rating consensus is 'Buy'. The analyst rating breakdown for SLGC stock is 0 'Strong Buy' (0.00%), 3 'Buy' (75.00%), 1 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
SomaLogic Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 16, 2022 | - | Cowen & Co. | $9.00 | $4.25 | 111.76% | 328.57% |
| Jun 23, 2022 | - | Cowen & Co. | $11.00 | $5.00 | 120.00% | 423.81% |
| May 13, 2022 | - | Canaccord Genuity | $15.00 | $5.42 | 176.75% | 614.29% |
The latest SomaLogic stock forecast, released on Aug 16, 2022 by Cowen & Co. company, set a price target of $9.00, which represents a 111.76% increase from the stock price at the time of the forecast ($4.25), and a 328.57% increase from SLGC last price ($2.10).
SomaLogic Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $2.10 | $2.10 | $2.10 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of SomaLogic stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to SomaLogic's last price of $2.10. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 09, 2023 | B. Riley Securities | Neutral | Neutral | Hold |
| Oct 09, 2023 | B. Riley | Overweight | Overweight | Hold |
| Aug 16, 2022 | Cowen & Co. | Outperform | Outperform | Hold |
| Jun 23, 2022 | Cowen & Co. | Outperform | Outperform | Hold |
| May 13, 2022 | Canaccord Genuity | Buy | Buy | Hold |
SomaLogic's last stock rating was published by B. Riley Securities on Oct 09, 2023. The company gave SLGC a "Neutral" rating, the same as its previous rate.
SomaLogic Financial Forecast
SomaLogic Revenue Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | $22.05M | $20.47M | $20.38M | $41.71M | $22.98M |
| Avg Forecast | $46.05M | $40.94M | $35.82M | $20.77M | $20.48M | $19.82M | $18.02M | $16.55M | $19.77M |
| High Forecast | $47.67M | $42.37M | $37.08M | $21.50M | $20.90M | $20.52M | $18.65M | $17.13M | $20.46M |
| Low Forecast | $44.79M | $39.81M | $34.84M | $20.20M | $20.00M | $19.28M | $17.53M | $16.10M | $19.23M |
| # Analysts | - | - | 1 | 3 | 4 | 2 | 2 | 1 | 8 |
| Surprise % | - | - | - | - | 1.08% | 1.03% | 1.13% | 2.52% | 1.16% |
SomaLogic's average Quarter revenue forecast for Dec 23 based on 3 analysts is $20.77M, with a low forecast of $20.20M, and a high forecast of $21.50M. SLGC's average Quarter revenue forecast represents a -5.80% decrease compared to the company's last Quarter revenue of $22.05M (Sep 23).
SomaLogic EBITDA Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | 1 | 3 | 4 | 2 | 2 | 1 | 8 |
| EBITDA | - | - | - | - | $-28.08M | $-31.09M | $-41.26M | $-37.02M | $-33.08M |
| Avg Forecast | $-37.69M | $-33.50M | $-29.32M | $-17.00M | $-16.76M | $-16.22M | $-14.75M | $-13.55M | $-16.18M |
| High Forecast | $-39.02M | $-34.68M | $-30.35M | $-17.60M | $-17.11M | $-16.79M | $-15.27M | $-14.02M | $-16.75M |
| Low Forecast | $-36.66M | $-32.59M | $-28.51M | $-16.53M | $-16.37M | $-15.78M | $-14.34M | $-13.17M | $-15.74M |
| Surprise % | - | - | - | - | 1.68% | 1.92% | 2.80% | 2.73% | 2.04% |
undefined analysts predict SLGC's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than SomaLogic's previous annual EBITDA (undefined) of $NaN.
SomaLogic Net Income Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | 1 | 3 | 4 | 2 | 2 | 1 | 8 |
| Net Income | - | - | - | - | $-22.16M | $-24.77M | $-34.20M | $-32.94M | $25.33M |
| Avg Forecast | $287.09M | $249.92M | $293.46M | $-31.75M | $-31.75M | $-33.61M | $-39.22M | $-37.35M | $-28.01M |
| High Forecast | $253.31M | $220.52M | $258.94M | $-28.01M | $-28.01M | $-29.66M | $-34.60M | $-32.95M | $-24.72M |
| Low Forecast | $337.75M | $294.03M | $345.25M | $-37.35M | $-39.22M | $-39.54M | $-46.14M | $-43.94M | $-32.95M |
| Surprise % | - | - | - | - | 0.70% | 0.74% | 0.87% | 0.88% | -0.90% |
SomaLogic's average Quarter net income forecast for Sep 22 is $-37.35M, with a range of $-43.94M to $-32.95M. SLGC's average Quarter net income forecast represents a -247.45% decrease compared to the company's last Quarter net income of $25.33M (Mar 22).
SomaLogic SG&A Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | 1 | 3 | 4 | 2 | 2 | 1 | 8 |
| SG&A | - | - | - | - | $23.88M | $29.57M | $34.19M | $51.24M | $30.82M |
| Avg Forecast | $40.14M | $35.68M | $31.22M | $18.11M | $17.85M | $17.28M | $15.71M | $14.43M | $17.23M |
| High Forecast | $41.56M | $36.94M | $32.32M | $18.74M | $18.22M | $17.88M | $16.26M | $14.93M | $17.84M |
| Low Forecast | $39.04M | $34.71M | $30.37M | $17.61M | $17.43M | $16.80M | $15.28M | $14.03M | $16.76M |
| Surprise % | - | - | - | - | 1.34% | 1.71% | 2.18% | 3.55% | 1.79% |
SomaLogic's average Quarter SG&A projection for Dec 23 is $18.11M, based on 3 Wall Street analysts, with a range of $17.61M to $18.74M. The forecast indicates a -24.18% fall compared to SLGC last annual SG&A of $23.88M (Sep 23).
SomaLogic EPS Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | 1 | 3 | 4 | 2 | 2 | 1 | 8 |
| EPS | - | - | - | - | $-0.12 | $-0.13 | $-0.18 | $-0.18 | $0.14 |
| Avg Forecast | $1.54 | $1.34 | $1.57 | $-0.17 | $-0.17 | $-0.18 | $-0.21 | $-0.20 | $-0.15 |
| High Forecast | $1.36 | $1.18 | $1.39 | $-0.15 | $-0.15 | $-0.16 | $-0.19 | $-0.18 | $-0.13 |
| Low Forecast | $1.81 | $1.57 | $1.85 | $-0.20 | $-0.21 | $-0.21 | $-0.25 | $-0.24 | $-0.18 |
| Surprise % | - | - | - | - | 0.71% | 0.72% | 0.86% | 0.90% | -0.93% |
According to 1 Wall Street analysts, SomaLogic's projected average Quarter EPS for Sep 22 is $-0.20, with a low estimate of $-0.24 and a high estimate of $-0.18. This represents a -242.86% decrease compared to SLGC previous annual EPS of $0.14 (Mar 22).
SomaLogic Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| RNLX | Renalytix | $0.21 | $2.00 | 852.38% | Buy |
| SLGC | SomaLogic | $2.10 | $12.00 | 471.43% | Buy |
| HCAT | Health Catalyst | $7.53 | $29.25 | 288.45% | Buy |
| EVH | Evolent Health | $12.35 | $40.86 | 230.85% | Buy |
| DH | Definitive Healthcare | $4.12 | $9.50 | 130.58% | Hold |
| FORA | Forian | $2.03 | $4.50 | 121.67% | Buy |
| SLP | Simulations Plus | $28.29 | $56.00 | 97.95% | Buy |
| PHR | Phreesia | $18.81 | $36.31 | 93.04% | Buy |
| PGNY | Progyny | $13.90 | $25.29 | 81.94% | Hold |
| PRVA | Privia Health Group | $20.95 | $33.82 | 61.43% | Buy |
| TALK | Talkspace | $2.99 | $2.50 | -16.39% | Hold |